524711-BOM

Vista Pharmaceuticals Ltd.

BSE: 524711

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

7.07-0.2 (-2.75%)

27 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

43.52

P/E (TTM)

P/B

1.19

P/S (TTM)

8.06

EV/EBITDA

CAPE (5Y)

ROE (TTM)

-29.47

ROCE (TTM)

-30.96

ROA (TTM)

-20.91

Avg 3Y ROE

-17.33

Earnings 3Y CAGR

-8.44

Sales 3Y CAGR

75.23

Sales 5Y CAGR

33.65

Debt/Equity

0.27

Consensus TP

Strong Buy %

Promoter Holding

21.19

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Vista Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -27.72% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Vista Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Vista Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Vista Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	38.14	38.14	31.48	31.48	35.29	35.29	36.94	36.94	35.44	35.44	35.44	35.44	35.44	30.51	29.51	27.81	27.81	21.19	21.19	21.19	21.19	21.19	21.19	21.19	21.19	21.19
Indian Promoter	2.47	2.47	2.04	2.04	2.04	2.04	2.04	2.04	2.04	2.04	19.92	19.92	19.92	30.51	16.59	15.63	15.63	11.91	11.91	11.91	11.91	11.91	11.91	11.91	11.91	11.91
Foreign Promoter	35.67	35.67	29.44	29.44	33.25	33.25	34.90	34.90	33.40	33.40	15.52	15.52	15.52	-	12.92	12.18	12.18	9.28	9.28	9.28	9.28	9.28	9.28	9.28	9.28	9.28
Institutions	0.34	0.34	0.28	0.28	0.28	0.28	0.16	0.16	0.04	0.04	0.04	0.04	0.04	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Mutual Funds / UTI	0.05	0.05	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.30	0.30	0.24	0.24	0.24	0.24	0.12	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	61.51	61.51	68.24	68.24	64.43	64.43	62.91	62.91	64.52	64.52	64.52	64.52	64.52	69.48	70.46	72.16	72.16	78.79	78.79	78.79	78.79	78.79	78.79	78.79	78.79	78.79
Bodies Corporate	2.32	2.23	1.82	1.82	1.40	1.39	1.39	1.39	1.21	1.23	1.02	1.34	1.02	0.40	0.32	0.44	0.44	0.22	0.22	0.23	0.59	0.59	0.59	0.54	0.55	0.55
Others (incl. Retail) No. of shareholders	59.19 11,237	59.28 11,310	66.42 11,347	66.42 11,594	63.03 11,564	63.04 12,745	61.52 12,926	61.52 12,926	63.31 14,306	63.29 14,625	63.50 14,617	63.18 14,836	63.50 14,725	69.08 14,580	70.14 14,184	71.72 13,842	71.72 13,949	78.57 13,818	78.57 13,849	78.56 14,020	78.20 14,091	78.20 13,994	78.20 13,945	78.25 14,013	78.24 14,087	78.24 14,087

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Vista Pharmaceuticals Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

Corporate Actions

History of Vista Pharmaceuticals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Others
Ex-date: 25th Jun 2015Announced on: 16th Jun 2015
Capital reduction of INR 150000000 into INR 50000000.
Stock Split1 : 5
Ex-date: 25th Jun 2015Announced on: 16th Jun 2015
Nominal value change from INR 10 to INR 2.

Company Profile

Overview of Vista Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Vista Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing of pharmaceutical products. The Company offers over the counter and prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The Company has i...

Key personnel

Suneel Pachipala

Chief Financial Officer

Ms. Barkha Jain

Compliance Officer, Company Secretary

Mr. Murali Meraga

Managing Director

Dr. Dhananjaya AlliD

Executive Chairman of the Board, Whole-Time Director

Mr. Pavan Sathvik GilakaD

Whole-Time Director

Dr. Stanely Prabhakar ReddyD

Additional Director

Shri. Mallem Hanumantha RaoD

Non-Executive Director

Mr. Divakar Reddy YerrabommanahalliD

Additional Non-Executive Director

View all

Incorporated on

25 Jan 1991

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

21 Jul 2003

Free Float

1,38,56,958

Website

https://vistapharmaceuticals.com/

Phone no.

+914023738872

Address

Plot No. 104, Ravindra Co-operative Housing Society, Guttala Begumpet Jubilee Hills, Shaikpet, , 500033, India

Frequently Asked Questions

What is the current share price of Vista Pharmaceuticals Ltd.?

The current share price of Vista Pharmaceuticals Ltd. is ₹ 7.07 as of 27 Jul 2026.

What is the market capitalisation of Vista Pharmaceuticals Ltd.?

The market capitalisation of Vista Pharmaceuticals Ltd. stands at ₹ 43.52 Cr.

What is the PE ratio of Vista Pharmaceuticals Ltd.?

The Price-to-Earnings (PE) ratio of Vista Pharmaceuticals Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Vista Pharmaceuticals Ltd.?

Vista Pharmaceuticals Ltd. has a Return on Equity (ROE) of -29.47% and a Return on Capital Employed (ROCE) of -30.96% as per the latest financial reports.

What is the 52-week high and low of Vista Pharmaceuticals Ltd.?

The 52-week high of Vista Pharmaceuticals Ltd. is - and the 52-week low is -.

What is the dividend yield of Vista Pharmaceuticals Ltd.?

The dividend yield of Vista Pharmaceuticals Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Vista Pharmaceuticals Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.02% and retail/public investors hold 78.24% of Vista Pharmaceuticals Ltd. shares.

What sector does Vista Pharmaceuticals Ltd. belong to?

Vista Pharmaceuticals Ltd. operates in the Healthcare sector.

What is the beta of Vista Pharmaceuticals Ltd.?

The beta of Vista Pharmaceuticals Ltd. is 0.49, indicating its price volatility relative to the broader market. Over the past 1 year, Vista Pharmaceuticals Ltd. has delivered an absolute return of -37.43%.

What is the RSI of Vista Pharmaceuticals Ltd.?

The 14-day Relative Strength Index (RSI) of Vista Pharmaceuticals Ltd. is 45.13, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Vista Pharmaceuticals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Vista Pharmaceuticals Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Corporate Actions